Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wentzel, P.
Right arrow Articles by Eriksson, U. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wentzel, P.
Right arrow Articles by Eriksson, U. J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 4 813-820, Copyright © 1999 by American Diabetes Association

ARTICLES

Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment

P Wentzel, N Welsh and UJ Eriksson
Department of Medical Cell Biology, University of Uppsala, Biomedicum, Sweden. parri.wentzel@medcellbiol.uu.se

Previous experimental studies suggest that diabetic embryopathy is associated with an excess of radical oxygen species (ROS), as well as with a disturbance of prostaglandin (PG) metabolism. We aimed to investigate the relationship between these pathways and used hyperglycemia in vitro (embryo culture for 24-48 h) and maternal diabetes in vivo to affect embryonic development. Subsequently, we assessed lipid peroxidation and gene expression of cyclooxygenase (COX)-1 and -2 and measured the concentration of prostaglandin E2 (PGE2) in embryos and membranes. Both hyperglycemia in vitro and maternal diabetes in vivo caused embryonic dysmorphogenesis and increased embryonic levels of 8-epi-PGF2alpha, an indicator of lipid peroxidation. Addition of N-acetylcysteine (NAC) to the culture medium normalized the morphology and 8-epi-PGF2alpha concentration of the embryos exposed to high glucose. Neither hyperglycemia nor diabetes altered COX-1 expression, but embryonic COX-2 expression was diminished on gestational day 10. The PGE2 concentration of day 10 embryos and membranes was decreased after exposure to high glucose in vitro or diabetes in vivo. In vitro addition of NAC to high glucose cultures largely rectified morphology and restored PGE2 concentration, but without normalizing the COX-2 expression in embryos and membranes. Hyperglycemia/diabetes-induced downregulation of embryonic COX-2 gene expression may be a primary event in diabetic embryopathy, leading to lowered PGE2 levels and dysmorphogenesis. Antioxidant treatment does not prevent the decrease in COX-2 mRNA levels but restores PGE2 concentrations, suggesting that diabetes-induced oxidative stress aggravates the loss of COX-2 activity. This may explain in part the antiteratogenic effect of antioxidant treatment.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
P. Wentzel, M. Gareskog, and U. J. Eriksson
Decreased Cardiac Glutathione Peroxidase Levels and Enhanced Mandibular Apoptosis in Malformed Embryos of Diabetic Rats
Diabetes, December 1, 2008; 57(12): 3344 - 3352.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
R. Higa, E. Gonzalez, M.C. Pustovrh, V. White, E. Capobianco, N. Martinez, and A. Jawerbaum
PPAR{delta} and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPAR{delta} activation in lipid metabolic and signalling pathways in rat embryo early organogenesis
Mol. Hum. Reprod., February 1, 2007; 13(2): 103 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. R. Loeken
Advances in Understanding the Molecular Causes of Diabetes-Induced Birth Defects
Reproductive Sciences, January 1, 2006; 13(1): 2 - 10.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
Z. Zhao and E. A. Reece
Experimental Mechanisms of Diabetic Embryopathy and Strategies for Developing Therapeutic Interventions
Reproductive Sciences, December 1, 2005; 12(8): 549 - 557.
[Abstract] [PDF]

Home page
 DiabetesHome page
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi
Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects
Diabetes, December 1, 2005; 54(12): 3418 - 3426.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
P. Nash, M. Olovsson, and U. J. Eriksson
Placental Dysfunction in Suramin-Treated Rats: Impact of Maternal Diabetes and Effects of Antioxidative Treatment
Reproductive Sciences, April 1, 2005; 12(3): 174 - 184.
[Abstract] [PDF]

Home page
 DiabetesHome page
P. Wentzel, A. Ejdesjo, and U. J. Eriksson
Maternal Diabetes In Vivo and High Glucose In Vitro Diminish GAPDH Activity in Rat Embryos
Diabetes, May 1, 2003; 52(5): 1222 - 1228.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y. Hiramatsu, N. Sekiguchi, M. Hayashi, K. Isshiki, T. Yokota, G. L. King, and M. R. Loeken
Diacylglycerol Production and Protein Kinase C Activity Are Increased in a Mouse Model of Diabetic Embryopathy
Diabetes, September 1, 2002; 51(9): 2804 - 2810.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.